Human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by AMP-activated protein kinase

Journal of Cellular Physiology

Volumn 227, Issue 4, 2012, Pages 1680-1687

  Kim, Eung Kyun ^a,b   Lim, Seyoung ^b   Park, Ji Man ^b   Seo, Jeong Kon ^b   Kim, Jae Ho ^c   Kim, Kyong Tai ^a   Ryu, Sung Ho ^a   Suh, Pann Ghill ^a,b  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Ulsan National Institute of Science and Technology   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCALCIN; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR RUNX2;

ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LINEAGE; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LENTIVIRINAE; MESENCHYMAL STEM CELL; MINERALIZATION; OSTEOBLAST; PRIORITY JOURNAL;

ADIPOGENESIS; AMP-ACTIVATED PROTEIN KINASES; BASE SEQUENCE; CELL DIFFERENTIATION; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; HUMANS; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STEM CELLS; OSTEOGENESIS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PYRAZOLES; PYRIMIDINES; RNA, SMALL INTERFERING;

LENTIVIRUS;

EID: 84862915613     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22892     Document Type: Article

References (56)

1. Adams M, Reginato MJ, Shao D, Lazar MA, Chatterjee VK. 1997. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 272:5128-5132.
2. Ali AA, Weinstein RS, Stewart SA, Parfitt AM, Manolagas SC, Jilka RL. 2005. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 146:1226-1235.
3. Asher G, Schibler U. 2011. Crosstalk between Components of Circadian and Metabolic Cycles in Mammals. Cell Metab 13:125-137.
4. Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, MacDougald OA. 2005. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA 102:3324-3329.
5. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F. 1998. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530.
6. Fulco M, Cen Y, Zhao P, Hoffman EP, McBurney MW, Sauve AA, Sartorelli V. 2008. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 14:661-673.
7. Ge C, Xiao G, Jiang D, Yang Q, Hatch NE, Roca H, Franceschi RT. 2009. Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor. J Biol Chem 284:32533-32543.
8. Giordano A, Galderisi U, Marino IR. 2007. From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells. J Cell Physiol 211:27-35.
9. Gutierrez GE, Edwards JR, Garrett IR, Nyman JS, McCluskey B, Rossini G, Flores A, Neidre DB, Mundy GR. 2008. Transdermal lovastatin enhances fracture repair in rats. J Bone Miner Res 23:1722-1730.
10. Habinowski SA, Witters LA. 2001. The effects of AICAR on adipocyte differentiation of 3T3-L1cells. Biochem Biophys Res Commun 286:852-856.
11. Hardie DG. 2004. The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 117:5479-5487.
12. Hardie DG. 2007. AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8:774-785.
13. Hardie DG, Scott JW, Pan DA, Hudson ER. 2003. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 546:113-120.
14. Hauschka PV, Lian JB, Cole DE, Gundberg CM. 1989. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol Rev 69:990-1047.
15. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG, Hardie DG. 2005. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2:9-19.
16. Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, Mueller E, Benjamin T, Spiegelman BM, Sharp PA, Hopkins N, Yaffe MB. 2005. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309:1074-1078.
17. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A. 2005. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7:393-395.
18. Hu E, Kim JB, Sarraf P, Spiegelman BM. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274:2100-2103.
19. Iseli TJ, Walter M, van Denderen BJ, Katsis F, Witters LA, Kemp BE, Michell BJ, Stapleton D. 2005. AMP-activated protein kinase beta subunit tethers alpha and gamma subunits via its C-terminal sequence (186-270). J Biol Chem 280:13395-13400.
20. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF. 2000. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 275:9645-9652.
21. Jorgensen SB, Viollet B, Andreelli F, Frosig C, Birk JB, Schjerling P, Vaulont S, Richter EA, Wojtaszewski JF. 2004. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 279:1070-1079.
22. Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Sugimoto T. 2008. Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1cells via AMP kinase activation as well as eNOS and BMP-2 expression. Biochem Biophys Res Commun 375:414-419.
23. Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Sugimoto T. 2009. Activation of AMP kinase and inhibition of Rho kinase induce the mineralization of osteoblastic MC3T3-E1cells through endothelial NOS and BMP-2 expression. Am J Physiol Endocrinol Metab 296:E139-E146.
24. Kasai T, Bandow K, Suzuki H, Chiba N, Kakimoto K, Ohnishi T, Kawamoto S, Nagaoka E, Matsuguchi T. 2009. Osteoblast differentiation is functionally associated with decreased AMP kinase activity. J Cell Physiol 221:740-749.
25. Kim JE, Ahn MW, Baek SH, Lee IK, Kim YW, Kim JY, Dan JM, Park SY. 2008. AMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblast. Bone 43:394-404.
26. Kim KA, Kim JH, Wang Y, Sul HS. 2007. Pref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation. Mol Cell Biol 27:2294-2308.
27. Koc ON, Lazarus HM. 2001. Mesenchymal stem cells: Heading into the clinic. Bone Marrow Transplant 27:235-239.
28. Komori T. 2008. Regulation of bone development and maintenance by Runx2. Front Biosci 13:898-903.
29. Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K, Bae YC, Jung JS. 2004. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14:311-324.
30. Lim S, Jang HJ, Kim JK, Kim JM, Park EH, Yang JH, Kim YH, Yea K, Ryu SH, Suh PG. 2011. Ochratoxin A inhibits adipogenesis through the extracellular signal-related kinases-peroxisome proliferator-activated receptor-γ pathway in human adipose tissue-derived mesenchymal stem cells. Stem Cells Dev 20:415-426.
31. Liu Q, Cen L, Zhou H, Yin S, Liu G, Liu W, Cao Y, Cui L. 2009. The role of ERK signaling pathway in osteogenic differentiation of human adipose-derived stem cells and in adipogenic transition initiated by dexamethasone. Tissue Eng Part A 15:3487-3497.
32. Luu YK, Capilla E, Rosen CJ, Gilsanz V, Pessin JE, Judex S, Rubin CT. 2009. Mechanical stimulation of mesenchymal stem cell proliferation and differentiation promotes osteogenesis while preventing dietary-induced obesity. J Bone Miner Res 24:50-61.
33. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. 1998. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4:415-428.
34. Marczak ED, Jinsmaa Y, Myers PH, Blankenship T, Wilson R, Balboni G, Salvadori S, Lazarus LH. 2009. Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent mu/delta-opioid receptor antagonist, regulates obese-related factors in mice. Eur J Pharmacol 616:115-121.
35. Maronde E, Schilling AF, Seitz S, Schinke T, Schmutz I, van der Horst G, Amling M, Albrecht U. 2010. The clock genes Period 2 and Cryptochrome 2 differentially balance bone formation. PLoS One 5:e11527.
36. Molinuevo MS, Schurman L, McCarthy AD, Cortizo AM, Tolosa MJ, Gangoiti MV, Arnol V, Sedlinsky C. 2010. Effect of metformin on bone marrow progenitor cell differentiation: In vivo and in vitro studies. J Bone Miner Res 25:211-221.
37. Ntambi JM, Young-Cheul K. 2000. Adipocyte differentiation and gene expression. J Nutr 130:3122S-3126S.
38. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
39. Prince M, Banerjee C, Javed A, Green J, Lian JB, Stein GS, Bodine PV, Komm BS. 2001. Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J Cell Biochem 80:424-440.
40. Quinn JM, Tam S, Sims NA, Saleh H, McGregor NE, Poulton IJ, Scott JW, Gillespie MT, Kemp BE, van Denderen BJ. 2010. Germline deletion of AMP-activated protein kinase {beta} subunits reduces bone mass without altering osteoclast differentiation or function. FASEB J 24:275-285.
41. Raisz LG, Kream BE. 1983. Regulation of bone formation. N Engl J Med 309:29-35.
42. Rzonca SO, Suva LJ, Gaddy D, Montague DC, Lecka-Czernik B. 2004. Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 145:401-406.
43. Sajan MP, Bandyopadhyay G, Miura A, Standaert ML, Nimal S, Longnus SL, Van Obberghen E, Hainault I, Foufelle F, Kahn R, Braun U, Leitges M, Farese RV. 2010. AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC. Am J Physiol Endocrinol Metab 298:E179-E192.
44. Salasznyk RM, Klees RF, Hughlock MK, Plopper GE. 2004. ERK signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells on collagen I and vitronectin. Cell Commun Adhes 11:137-153.
45. Sengupta S, Park SH, Patel A, Carn J, Lee K, Kaplan DL. 2010. Hypoxia and amino acid supplementation synergistically promote the osteogenesis of human mesenchymal stem cells on silk protein scaffolds. Tissue Eng Part A 16:3623-3634.
46. Shah M, Kola B, Bataveljic A, Arnett TR, Viollet B, Saxon L, Korbonits M, Chenu C. 2010. P-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. Bone 47:309-319.
47. Shimba S, Ishii N, Ohta Y, Ohno T, Watabe Y, Hayashi M, Wada T, Aoyagi T, Tezuka M. 2005. Brain and muscle Arnt-like protein-1 (BMAL1), a component of the molecular clock, regulates adipogenesis. Proc Natl Acad Sci USA 102:12071-12076.
48. Short B, Brouard N, Occhiodoro-Scott T, Ramakrishnan A, Simmons PJ. 2003. Mesenchymal stem cells. Arch Med Res 34:565-571.
49. Song HY, Jeon ES, Kim JI, Jung JS, Kim JH. 2007. Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells. J Cell Biochem 101:1238-1251.
50. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M. 2002. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62:3603-3608.
51. Sun W, Lee TS, Zhu M, Gu C, Wang Y, Zhu Y, Shyy JY. 2006. Statins activate AMP-activated protein kinase in vitro and in vivo. Circulation 114:2655-2662.
52. Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, Igarashi M, Youn MY, Takeyama K, Nakamura T, Mezaki Y, Takezawa S, Yogiashi Y, Kitagawa H, Yamada G, Takada S, Minami Y, Shibuya H, Matsumoto K, Kato S. 2007. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol 9:1273-1285.
53. Um JH, Yang S, Yamazaki S, Kang H, Viollet B, Foretz M, Chung JH. 2007. Activation of 5′-AMP-activated kinase with diabetes drug metformin induces casein kinase Iepsilon (CKIepsilon)-dependent degradation of clock protein mPer2. J Biol Chem 282:20794-20798.
54. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Geloen A, Flamez D, Mu J, Lenzner C, Baud O, Bennoun M, Gomas E, Nicolas G, Wojtaszewski JF, Kahn A, Carling D, Schuit FC, Birnbaum MJ, Richter EA, Burcelin R, Vaulont S. 2003. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 111:91-98.
55. Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G, Franceschi RT. 2000. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J Biol Chem 275:4453-4459.
56. Zheng Q, Huang G, Yang J, Xu Y, Guo C, Xi Y, Pan Z, Wang J. 2007. Could the effect of modeled microgravity on osteogenic differentiation of human mesenchymal stem cells be reversed by regulation of signaling pathways? Biol Chem 388:755-763.